Category: Uncategorized

KUALA LUMPUR, July 1 (Bernama) — A promo video for Fuzhou City of Fujian Province entitled ‘Things You Don’t Know about Fuzhou — Heart of the Min River’ was premiered on July 1 via overseas social media accounts including Oriental.Paris, Discover Fujian and Discover Fuzhou.

The video showcased the new characters of this thousand-year-old city which is underlined by green development, cultural legacy, innovation and passion. In the video, the Min River stretches across the hustle and bustle of this thriving city.

Also featured in the video are Binjiang Pedestrian Street, a commercial street with a long history; the Youth Square, which boasts the largest lawn in the city centre of Fuzhou and offers the best view of the Min River; and, the Youth Bridge, which links the historic neighbourhood and the Square.

Classic Min-style architecture is seamlessly fitted into a modern, international cityscape, together with newly built photo-friendly attractions, a gorgeous landscape has been created along the Mother River of Fujian — the Min River, according to the Publicity Department of the CPC Fuzhou Municipal Committee in a statement.

In recent years, Fuzhou has been using the Min River as an important development axis in its efforts to build a modern, international metropolis.

With the aim of transforming the banks of the Min River into an attractive venue where people can get together and relax, Fuzhou launched a new project to improve the landscape in key areas of the ‘Heart of Min River’.

— BERNAMA

Global experts from the United Nations Environment Programme, The Nature Conservancy, governments, research agencies, and the private sector are coming together to share best practices in improving marine management based on lessons learned around the world.

LISBON, Portugal, June 29 (Bernama-BUSINESS WIRE) — Marine protected areas (MPAs) are key tools for reducing threats to biodiversity, safeguarding marine and coastal habitats, building climate solutions, and supporting human needs through sustainable use. The Convention on Biological Diversity’s Global Biodiversity Framework may include an ambitious target of expanding MPA coverage to 30% by 2030. However, less than 3% of marine protected areas are meeting their objectives in the face of accelerating local and global threats.

This press release features multimedia. View the full release here: 
https://www.businesswire.com/news/home/20220628005443/en/

To tackle this challenge, a team of experts is convening at the United Nations Oceans Conference in June 2022 in Lisbon, Portugal in a side event entitled, “Quality Matters: Enhancing Governance, Effective Management and Resilience of Marine Protected Areas for Multiple Co-benefits.” The event includes speakers from the private sector, local marine science agencies, representatives from non-profit organizations, governments, and intergovernmental organizations. Speakers will share how they are spearheading technological innovation and best practices in marine management and will spotlight valuable tools, increase collaboration, knowledge sharing, and uptake of lessons learned. Dr. Lizzie McLeod, Global Reefs Lead for The Nature Conservancy notes, “Strong partnerships including the private sector, governments, NGOs, researchers, and local communities are essential to improving ocean health. Harnessing lessons learned and best practices globally to improve ocean management is a conservation priority including the co-creation of solutions with key partners.”

Building on this event, the United Nations Environment Programme, The Nature Conservancy, and other conservation partners, with support from Mary Kay Inc., are developing a suite of decision support tools for marine managers that improve marine management, support the sustainable financing of marine protected areas, and guide marine habitat restoration building on best practices around the world. By leveraging scientific innovation and new technologies and global best practices, marine managers are better able to tackle major threats facing marine ecosystems around the world. “MPAs are key to ocean health and sustainable development. But they are not always effective without a range of support. Decision support tools that enable improved MPA design and management, knowledge sharing, and collaboration are needed to give marine stakeholders the support they need to better protect the oceans,” said Ole Vestergard, Programme Officer, United Nations Environment Programme.

“Mary Kay is delighted to support TNC, in collaboration with UNEP and other experts from around the world, in an effort to protect our world’s most precious assets: oceans,” said Deborah Gibbins, Mary Kay’s Chief Operating Officer. “These organizations are on the frontlines of the fight to preserve our waterways, and we’re hopeful that with Mary Kay’s support, they’ll have the tools and resources needed to ensure our oceans are healthy for generations to come.

As governments refine their conservation targets, it is timely to highlight new innovations and technologies that help countries meet global biodiversity and sustainable development goals. New decision tools and foundational science are needed to enhance the capacity of marine planners and managers to better manage marine habitats in the face of climate change and other threats.

About The Nature Conservancy

The Nature Conservancy is a global conservation organization dedicated to conserving the lands and waters on which all life depends. Guided by science, we create innovative, on-the-ground solutions to our world’s toughest challenges so that nature and people can thrive together. We are tackling climate change, conserving lands, waters, and oceans at an unprecedented scale, providing food and water sustainably, and helping make cities more sustainable. Working in 79 countries and territories, we use a collaborative approach that engages local communities, governments, the private sector, and other partners. To learn more, visit www.nature.org or follow @nature_press on Twitter.

About the United Nations Environment Programme (UNEP)

UNEP is the leading global voice on the environment. It provides leadership and encourages partnership in caring for the environment by inspiring, informing, and enabling nations and peoples to improve their quality of life without compromising that of future generations.

About Mary Kay

One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors of domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on Twitter.

View source version on businesswire.com: 
https://www.businesswire.com/news/home/20220628005443/en/

Contact

Mary Kay Inc. Corporate Communications
marykay.com/newsroom
972.687.5332 or media@mkcorp.com

Misty Edgecomb
Communications Director, Protect Oceans, Land and Water
The Nature Conservancy
Las Vegas, Nevada (Pacific time zone)
medgecomb@tnc.org, 484-343-3223 cell
pronouns: she/her, Twitter: @mistyedgecomb

Source : Mary Kay Inc.

http://mrem.bernama.com/viewsm.php?idm=43537

DALLAS, June 24 (Bernama-BUSINESS WIRE) — Mary Kay Inc., a global leader in skincare innovation, recently sponsored and revealed its inaugural Mary Kay Skin Health/Skin Disease Research Grants awardees for researchers conducting groundbreaking, innovative studies in skin health and skin disease at the 2022 Society for Investigative Dermatology (SID) Annual Meeting.

This press release features multimedia. View the full release here: 
https://www.businesswire.com/news/home/20220623005229/en/

“As a decades-long leader in global cosmetics and skincare innovation, Mary Kay remains committed to enriching women’s lives across the world,” said Dr. Lucy Gildea, Mary Kay’s Chief Innovation Officer, Product and Science, at the event. “We also have a steadfast commitment to producing the highest quality products and conducting breakthrough skin science research. We recognize collaboration is crucial to new discoveries, and partnerships with scientific, medical, and academic communities are vital collaborations—which is why we’re thrilled to award these scientific grants.”

The Mary Kay Skin Health/Skin Disease Research Grants were announced at last year’s meeting in partnership with SID. The $25,000 grants were to be awarded to four researchers conducting incredible work in skin research to uncover new perspectives and invention strategies. In the months following the 2021 SID meeting, the company received applications from scientists across the country.

The four grant awardees ultimately selected were:

· Dr. Allison C. Billi, MD, Ph.D., and Assistant Professor in the Dept of Dermatology at the University of Michigan. Dr. Billi’s primary research goal is to understand “what drives photoaging.” The grant will fund research to identify targetable pathways that help prevent or potentially reverse the effects of photoaging.
· Dr. Angel S. Byrd, MD, Ph.D. and Assistant Professor at Howard University College of Medicine and Adjunct Assistant Professor at JHUSOM (Departments of Dermatology). Dr. Byrd’s work focuses on the genetic basis of melasma. This grant will fund research to help discover unknown genetic causes of melasma to design personalized treatment options.
· Dr. Mae Alexandra Carpenter, Ph.D. Trainee at Wright State University. Dr. Carpenter’s work explores how damaged DNA-containing particles are released and how they activate inflammatory pathways. Funding this research will help develop new therapeutic approaches to reduce UVB photosensitivity in autoinflammatory diseases.
· Dr. Jennifer Powers, MD and Clinical Associate Professor in the Dept of Dermatology at the University of Iowa. Dr. Powers is interested in the influence of the microbiome and the healing environment on wound healing and scar formation. Funding for this research will help understand how the immune system and microbiota interact to modify scar formation from ulcers and surgical wounds.

“Congratulations to each of our 2022 grant award recipients,” added Dr. Gildea. “These individuals were carefully chosen in collaboration with the Society for Investigative Dermatology—and we are thrilled to support their research.”

The sponsorship and grants revealed at SID are just the latest efforts by Mary Kay to reinforce the company’s long-standing commitment to advancing skin health research and development. Mary Kay holds more than 1,600 patents for products, technologies, and packaging designs in its global portfolio.

About Mary Kay

One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey to economic independence through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on Twitter.

View source version on businesswire.com: 
https://www.businesswire.com/news/home/20220623005229/en/

Contact

Mary Kay Inc. Corporate Communications
marykay.com/newsroom
972.687.5332 or media@mkcorp.com

Source : Mary Kay

–BERNAMA

KUALA LUMPUR, June 23 (Bernama) — INNIO, a leading energy solution and service provider, has published its Sustainability Report for 2021 Together Towards Zero, which defines the company’s performance in meeting environmental, social, and governance (ESG) goals.

While INNIO is currently empowering industries and communities to transition to net zero, this report – prepared in accordance with GRI and SASB standards – formally communicates on progress and sustainability-related performance providing, transparency about how INNIO is contributing to a green tomorrow.

In a statement, INNIO chief executive officer Dr Olaf Berlien states: “I’m incredibly proud of the steps we have taken to implement our ESG strategy.

“The outstanding recognition we have received for our achievements with leading ESG ratings shows that we are on the right track on our path to net zero.”

In accordance with global frameworks and commitments, INNIO set out ambitious sustainability targets in three strategic focus areas where it sees the most material impacts and opportunities for improvement: Low Carbon and Circular Products, Resilient Supply Chain and Manufacturing, and Responsible Operations and Social Responsibility.

Selected key ambitions in these areas include INNIO offering since 2022, all new engines with a ‘Ready for H2’ option; imperative that suppliers covering 80 per cent of direct and indirect spend commit to net zero by 2050; and, by 2025, an increase of identified diversity groups by 25 per cent across functions compared to the 2020 baseline.

INNIO’s 2021 Sustainability Report is a non-financial disclosure published annually, prepared in accordance with the standards of the Global Reporting Initiative (GRI) core option and the Sustainability Accounting Standards Board (SASB).

INNIO is headquartered in Jenbach (Austria).

For more information, visit http://www.innio.com.

— BERNAMA

KUALA LUMPUR, June 14 (Bernama) — Impulse Dynamics, a commercial-stage medical device company focused on delivering CCM therapy to people with heart failure, announced that the first implants in Europe for the newly launched Optimizer® Smart Mini device were recently completed in Italy.

According to a statement, the company announced the launch of the new technology on April 29, 2022, and the first U.S. implants on May 10, 2022.

In March 2022, the company announced that its quality management system received certification under the new European Union Medical Device Regulation.

The new components of the Optimizer Smart Mini system are equally important across international markets, including a rechargeable battery with a 20-year life and new internal technology with improved programming and potential for remote monitoring in a smaller design to make the implant procedure easier for patients and physicians.

“The pace of this international rollout is a reflection of our commitment to delivering innovation that is relevant to patients worldwide,” said Mateusz Zelewski, MD, Impulse Dynamics’ Vice President International.

“It is exciting to see how quickly we can increase access to new and better technology that offers hope for more patients living with heart failure.”

The Optimizer Smart Mini delivers CCM therapy, which consists of electric pulses applied to the heart between heartbeats and serves to enhance the performance of cardiac muscular contraction, making the heart work more efficiently without increasing the heart rate or the oxygen consumption of the cardiac muscle.

CCM therapy is currently indicated in Europe to reduce hospitalisations and improve physical exercise tolerance, quality of life, and functional status for a large population of patients with systolic heart failure who remain symptomatic despite guideline-directed medical therapy.

To date, CCM therapy has already been used to treat over 7,000 patients worldwide and is available in 44 countries. The therapy has been studied in almost 2,000patients and has appeared in more than 100 peer-reviewed journal articles.

More details at http://www.ImpulseDynamics.com.

— BERNAMA